These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17336181)

  • 1. Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis.
    Sullivan PB; Lewindon PJ; Cheng C; Lenehan PF; Kuo BS; Haskins JR; Goodlad RA; Wright NA; de la Iglesia FA
    J Pediatr Surg; 2007 Mar; 42(3):462-9. PubMed ID: 17336181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis.
    Nair RR; Warner BB; Warner BW
    Semin Perinatol; 2008 Apr; 32(2):107-13. PubMed ID: 18346534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis.
    Feng J; El-Assal ON; Besner GE
    Semin Pediatr Surg; 2005 Aug; 14(3):167-74. PubMed ID: 16084404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.
    Feng J; El-Assal ON; Besner GE
    J Pediatr Surg; 2006 Jan; 41(1):144-9; discussion 144-9. PubMed ID: 16410124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model.
    Dvorak B; Halpern MD; Holubec H; Williams CS; McWilliam DL; Dominguez JA; Stepankova R; Payne CM; McCuskey RS
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G156-64. PubMed ID: 11751169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis.
    Warner BW; Warner BB
    Semin Pediatr Surg; 2005 Aug; 14(3):175-80. PubMed ID: 16084405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis.
    Feng J; El-Assal ON; Besner GE
    J Pediatr Surg; 2006 Apr; 41(4):742-7; discussion 742-7. PubMed ID: 16567187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
    Dvorak B; Khailova L; Clark JA; Hosseini DM; Arganbright KM; Reynolds CA; Halpern MD
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor and necrotizing enterocolitis.
    Coursodon CF; Dvorak B
    Curr Opin Pediatr; 2012 Apr; 24(2):160-4. PubMed ID: 22227788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis.
    Halpern MD; Holubec H; Clark JA; Saunders TA; Williams CS; Dvorak K; Dvorak B
    Biol Neonate; 2006; 89(4):227-35. PubMed ID: 16319449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis.
    Clark JA; Lane RH; Maclennan NK; Holubec H; Dvorakova K; Halpern MD; Williams CS; Payne CM; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G755-62. PubMed ID: 15528252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
    Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
    Feng J; Besner GE
    J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interleukin-11 and epidermal growth factor on residual small intestine after experimental massive small bowel resection.
    Ledniczky G; Fiore N; Bognár G; Ondrejka P; Grosfeld JL
    Chirurgia (Bucur); 2006; 101(2):127-33. PubMed ID: 16752677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is EGF the Holy Grail for NEC?
    Caplan M
    J Pediatr; 2007 Apr; 150(4):329-30. PubMed ID: 17382103
    [No Abstract]   [Full Text] [Related]  

  • 16. Soybean-derived recombinant human epidermal growth factor protects against experimental necrotizing enterocolitis.
    Isani M; Illingworth L; Herman E; Schmidt M; Barron L; Bowling J; Elizee M; Bai I; Gayer C; Grishin A; Erwin CR; Ford HR; Warner BW
    J Pediatr Surg; 2018 Jun; 53(6):1203-1207. PubMed ID: 29636182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome.
    Sigalet DL; Martin GR; Butzner JD; Buret A; Meddings JB
    J Pediatr Surg; 2005 May; 40(5):763-8. PubMed ID: 15937810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis.
    Fell JM
    Early Hum Dev; 2005 Jan; 81(1):117-22. PubMed ID: 15707723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis.
    Maynard AA; Dvorak K; Khailova L; Dobrenen H; Arganbright KM; Halpern MD; Kurundkar AR; Maheshwari A; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G614-22. PubMed ID: 20539009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet- and colonization-dependent intestinal dysfunction predisposes to necrotizing enterocolitis in preterm pigs.
    Sangild PT; Siggers RH; Schmidt M; Elnif J; Bjornvad CR; Thymann T; Grondahl ML; Hansen AK; Jensen SK; Boye M; Moelbak L; Buddington RK; Weström BR; Holst JJ; Burrin DG
    Gastroenterology; 2006 May; 130(6):1776-92. PubMed ID: 16697741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.